Causes and consequences of comorbidity: a review.
By R. Gijsen, N. Hoeymans, F. Schellevis, D. Ruwaard, W. Satariano, G. V. D. van den Bos. Journal of Clinical Epidemiology, 2001
997 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Economics and Econometrics, Epidemiology
View Paper: https://www.semanticscholar.org/paper/63fdbba9eb16f78c7f5b0e4544fa7d55b0978819
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Economics and Econometrics
Citations in the corpus
- How to measure comorbidity. a critical review of available methods. (2003, background): “Although there is a growing body of evidence that comorbidity, as a disease count or an index, is an independent predictor of several outcomes [33,35,56], relatively little is known about the effect of individual disease combinations on the outcome of interest [50,52,53].”
- Review: Health Care Utilization and Costs of Elderly Persons With Multiple Chronic Conditions (2011, background): “Notable exceptions are Fortin et al. (2004), who reviewed studies investigating MCCs and quality of life in primary care; Gijsen et al. (2001), who summarized studies on causes and consequences (e.g., mortality, functional status/quality of life, HCU, complications) of comorbidity in several…”
- Multimorbidity patterns: a systematic review. (2014, background): “Unraveling associations that may not logically follow previous biomedical research offers promising directions for future research, [3] and in this sense, some of the studies reviewed suggest that medications could be a risk factor in the aggregation of certain diseases [22,26].”
- The development of a comorbidity index with physical function as the outcome. (2005, background): “5% of variance in breast cancer mortality [17], and the Index of Coexistent Disease (ICED) [24], previously recommended for adjustment of comorbid disease when functional status is the outcome of interest [53], accounted for 14% of the variance in the occurrence of serious in hospital complications ”
- Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. (2005, background): “creased risk for adverse drug events and mortality.(2-4) Optimizing care for this population is a high priority.”
- Multiple Chronic Conditions: Prevalence, Health Consequences, and Implications for Quality, Care Management, and Costs (2007, background): “However, there has been very little research to date exploring the prevalence of particular combinations or clusters of chronic conditions, and almost all studies examining specific comorbidities do so from the perspective of a specific index disease rather than examining all co-occurring chronic co”
- Future of Multimorbidity Research: How Should Understanding of Multimorbidity Inform Health System Design? (2010, background): “Patients with multimorbidity and complex healthcare needs often receive care that is fragmented, incomplete, inefficient, and ineffective.(11,23,48,77,78) For example, in addition to associations with high costs and utilization, the risk of potentially avoidable inpatient admissions or preventable c”